Articles by Maribel Rios - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Maribel Rios

FDA 'Concerned' after Germany Reports More Heparin-Related Illnesses

Mar 13, 2008

Concerns over contaminated heparin product worsened as US officials announced dialysis patients in Germany have fallen ill after using a different brand of the blood thinner than was already being recalled.

Pittcon 2008 Unveils Innovations in Analytics

Mar 6, 2008

The 59th Pittsburgh Conference gathered more than 1000 exhibitors on its showroom floor this week.

New Dimensions in Tablet Imaging

Chemical imaging of solid dosage forms has become a powerful analytical tool for the development of solid dosage forms.
Mar 2, 2008

Chemical imaging of solid dosage forms has become a powerful analytical tool for the development of solid dosage forms.

Merck Invests $1.5 Million in TEM Imaging Service Laboratory

Feb 28, 2008

Merck Capital Ventures, a subsidiary of Merck & Co., has invested $1.5 million to expand its service laboratory. The transaction with NanoImaging Services will add high-resolution, three-dimensional transmission electron microscope (TEM) capability, which allows biopharmaceutical researchers to see complex macromolecular structures they create with resolution as high as one nanometer.

Vintage Pharmaceuticals Receives Warning Letter

Feb 21, 2008

The US Food and Drug Administration has issued generics manufacturer Vintage Pharmaceuticals a warning letter stemming from July through August 2007 that found observations pertaining to microbial contamination and failures in testing and documentation procedures.

Gene Regulator Key to New Cancer Therapies

Feb 14, 2008

Scientists at The Wistar Institute are taking further steps into understanding a gene regulator that can lead them closer to developing new cancer therapies.

Amgen, Takeda Announce R&D Partnership

Feb 7, 2008

Amgen will partner with R&D firm Takeda Pharmaceutical Company Ltd. toward the development and commercialization of 13 of Amgen?s molecules, with one included as an option.

Clearing the Air on Residual Solvents

USP 9467: Residual Solvents will take effect on July 1, 2008. But does the industry understand these specifications—and is it prepared?
Feb 2, 2008

USP 467 Residual Solvents will take effect on July 1, 2008. But does the industry understand these specifications—and is it prepared?

Congress Opposes FDA’s Proposed Rule on Labeling Changes

Feb 1, 2008

Members of Congress have strongly urged the US Food and Drug Administration to reconsider its proposed rule to amend regulations permitting companies to promptly update their drug and device labels with new safety information.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
26%
Attracting a skilled workforce
29%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
31%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
FindPharma Custom Search
Click here